Skip to main content
. 2020 Apr 20;103(1):508–514. doi: 10.4269/ajtmh.19-0877

Table 4.

Intensive care unit-AI before and after the studied episode of ICU-BSI

Site of ICU-AI ICU-AI before the first ICU-BSI, n (%) The first ICU-BSI,*n (%) ICU-AI after the first ICU-BSI, n (%) Total, n (%)
Without BSI With BSI
Primary BSI 0 98 (62.4) 0 59 (37.6) 157 (100)
Ventilator-associated pneumonia 42 (29.8) 57 (40.4) 34 (24.1) 8 (5.7) 141 (100)
Catheter-related 9 (10,3) 39 (44.8) 15 (17.2) 24 (27.6) 87 (100)
Urine 5 (17,2) 15 (51.7) 6 (20.7) 3 (10.3) 29 (100)
Cutaneous 2 (20) 5 (50) 1 (10) 2 (20) 10 (100)
Pulmonary 2 (20) 4 (40) 3 (30) 1 (10) 10 (100)
Abdominal 0 2 (40) 2 (40) 1 (20) 5 (100)
Endocardial 0 2 (100) 0 0 2 (100)
Surgical site infection 0 1 (50) 0 1 (50) 2 (100)
Bronchitis 1 (50) 0 1 (50) 0 2 (100)
Gynecologic 1 (100) 0 0 0 1 (100)
Ophthalmic 1 (100) 0 0 0 1 (100)
Bone 1 (33,3) 0 2 (66.7) 0 3 (100)
Sinusitis 0 0 1 (100) 0 1 (100)
Neuromeningeal 0 0 2 (100) 0 2 (100)
Total 64 223 67 99 453

ICU = intensive care unit; ICU-BSI = intensive care unit–acquired bloodstream infection.

*

The studied episode.